Within the DM–PD–CVD triad, NF-κB activation drives pro-inflammatory cytokine release (IL-6, TNF-α), endothelial adhesion molecule expression (ICAM-1, VCAM-1), and amplifies systemic low-grade inflammation. Here, NFKB1 is linked to diabetes mellitus.